Human decidua-associated protein (hDP) 200 identified as a monoclonal rheumatoid factor is not an acute phase reactant

American Journal of Reproductive Immunology

Volumn 37, Issue 2, 1997, Pages 195-198

  Halperin, Reuvit ^a   Schneider, David ^b   Maymon, Ron ^b   Bukovsky, Ian ^b   Hadas, Eran ^b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b NONE

Author keywords

hDP 200; Immunoglobulin; Intra uterine device; Pelvic inflammatory disease; Rheumatoid factor; Uterine fluid

Indexed keywords

ACUTE PHASE PROTEIN; MONOCLONAL ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE FERTILITY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; METRITIS; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; REPRODUCTION; UTERUS FLUID;

EID: 0031040499     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00213.x     Document Type: Article

References (11)

1. Halperin R, Kraicer PF, Hadas E. Identification, immunoaffinity purification and partial characterization of a human decidua-associated protein. J Reprod Fertil 1990; 88:159-165.
2. Halperin R, Kraicer PF, Hadas E. Human decidua-associated protein hDP 200 appears to he a rheumatoid factor. J Reprod Fertil 1994; 100:425-427.
3. Halperin R, Herman A, Golan A, Hadas E, Schneider D, Bukovsky I, Ron-El R. Sequential measurements of human decidua-associated protein (hDP) 200 in the uterine fluid during the menstrual cycle. Am J Reprod Immunol 1996; 35:102-105.
4. Halperin R, Schneider D, Kraicer PF, Hadas E, Rheumatoid factor associated high molecular weight complexes in the menstrual and amniotic fluids. Gynecol obstet Invest 1996; 41:220-223.
5. Halperin R, Ron-El R, Golan A, Hadas E, Scheider D, Bukovsky I, Herman A. Uterine fluid human decidua-associated protein 200 and implantation after embryo transfer. Human Reprod 1995; 10:907-910.
6. Halperin R, Bracha Y, Schneider D, Maymon R, Kraicer PF, Hadas E. Human decidua-associated protein hDP 200 in menstrual fluid: Comparison between fertile women and women after failed in-vitro fertilization/embryo transfer treatment. Human Reprod 1995; 10:324-327.
7. Kutteh WH, Blackwell RE, Gore H, Kutteh CC, Carr BR, Mestecky J. Secretory immune system of the female reproductive tract II. Local immune system in normal and infected fallopian tube. Fertil Steril 1990; 54:51-55.
8. Chandra RK, Malkani PK, Bhasin K. Levels of immunoglobulins in the serum and uterine fluid of women using an intrauterine contraceptive device. J Reprod Fertil 1974; 37:1-16.
9. Tauber PF, Cramer GM, Zaneveld LJ. Effect of the intrauterine contraceptive device on protein components of human uterine fluid. Contraception 1993; 48:494-512.
10. Wollen AL, Sandvei R, Mork S, Marandon JL, Matre R. In situ characterization of leukocytes in the fallopian tube in women with or without an intrauterine contraceptive device. Acta Obstet Gynecol Scand 1994; 73:103-112.
11. Gilliland BC, Mannik M. Rheumatoid arthritis. In Harrison's Principles of Internal Medicine. RG Petersdorf, RD Adams, E. Braunwald, KJ Isselbacher, JB Martin, JD Wilson (eds). New York, McGraw-Hill, Inc., 1983, pp. 1977-1986.